https://www.selleckchem.com/pr....oducts/sitravatinib-
PRM may be a safe, useful, and cost-effective technique for non-experts learning to perform colorectal ESD. Lenvatinib, a multitargeted tyrosine kinase inhibitor, was recently approved for hepatocellular carcinoma (HCC) treatment in Japan; however, the association between proteinuria following lenvatinib administration in HCC patients and early mortality is unknown. This study aimed to examine the association between nephrotic-range proteinuria (NRP) and mortality and evaluated the risk factors for NRP among Japanese HCC pa
Like
Comment
Share
